AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.823
-0.027 (-3.21%)
Nov 7, 2024, 3:24 PM EST - Market open
AEON Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 33 | 268 | 1,395 | 214 | - | - | |
Market Cap Growth | -95.82% | -80.82% | 553.24% | - | - | - | |
Enterprise Value | 45 | 252 | 1,642 | 428 | - | - | |
Last Close Price | 0.85 | 7.20 | 10.05 | 9.71 | - | - | |
PE Ratio | - | -1.75 | -26.55 | -22.03 | - | - | |
PB Ratio | -1.47 | -1.75 | -10.53 | -2.49 | - | - | |
P/FCF Ratio | -0.95 | -5.59 | -38.87 | -7.47 | - | - | |
P/OCF Ratio | -0.95 | -5.59 | -39.21 | -7.51 | - | - | |
EV/EBITDA Ratio | -1.02 | -4.77 | -33.96 | -11.62 | - | - | |
EV/EBIT Ratio | -1.02 | -4.76 | -33.91 | -11.61 | - | - | |
EV/FCF Ratio | -1.03 | -5.26 | -45.76 | -14.98 | - | - | |
Debt / Equity Ratio | -0.53 | 0.00 | -0.99 | -1.01 | -1.11 | 0.42 | |
Debt / FCF Ratio | -0.34 | -0.01 | -3.67 | -3.04 | -7.63 | -0.67 | |
Asset Turnover | - | - | - | - | 0.04 | 0.02 | |
Quick Ratio | 0.33 | 0.40 | 0.12 | 0.25 | 4.81 | 6.40 | |
Current Ratio | 0.39 | 0.48 | 0.12 | 0.25 | 4.85 | 6.41 | |
Return on Equity (ROE) | - | - | - | - | -968.74% | 2427.18% | |
Return on Assets (ROA) | -597.69% | -374.77% | -351.67% | -166.73% | -15.11% | -20.86% | |
Return on Capital (ROIC) | - | - | -17752.57% | -584.37% | -18.81% | -31.10% | |
Earnings Yield | -918.64% | -143.76% | -3.77% | -26.05% | - | - | |
FCF Yield | -130.49% | -17.88% | -2.57% | -13.39% | - | - | |
Buyback Yield / Dilution | 68.99% | 32.71% | -9.98% | -1813.86% | 0.74% | -0.58% | |
Total Shareholder Return | 68.99% | 32.71% | -9.98% | -1813.86% | 0.74% | -0.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.